BPTH - Good News in Dec = Enormous ProfitsBPTH, the ticker to the company Bio Path Holdings is currently trending down. This ticker has been a poor performer for the entire year with small time periods where day traders may make an easy 20-60 percent. Bio Path may seem like a decent day trading target where it follows the downward trending line and tends to bounce up a few days after coming into contact with it. If this continues, one can easily make short term gains and find value in this, but it will make much more sense to wait.
Bio Path will be releasing news on its number one drug, Prexigebersen for Acute Myeloid Leukemia (AML). This drug with good data has the potential of making Bio Path a multi billion dollar company. As you can see last year, Bio Path jumped from a startling ~$1 per share to ~$70 per share with one good news release. It is not easy to find these opportunities very often, that's why timing is the key.
Bio Medical companies tend to slowly decrease in value or, "bleed" waiting for positive news from the company. This is due to the companies being unprofitable and often seek financing deals creating stock dilution. The good news is what makes the stock relatively value because of the opportunity for day traders to capitalize on large percentage gains with a simple news release, but at the same time, you could also lose a large amount if it were negative.
Bio Path will release news on Prexigebersen this December and if you don't know enough about it, I recommend you do a little research on your own.
Any investment in this company is indeed speculation. Investing with small positions is the proper strategy with bio-med.
Cheers,
AC
Gainers
(Nasdaq: CODX) Bullish signal - GOLDEN CROSSThis could be the next NASDAQ Biotech ready to move in a big way, here's why...
(Nasdaq: CODX) displaying the Holy grail of Bullish signals - a GOLDEN CROSS.
The 50 Day EMA just crossed the 200 Day EMA, which most of you know by now is a bullish signal that indicates a potential breakout is on the Horizon.
Here Is Another Potential "Breakout Catalyst" In Play
Wall Street Analysts at H.C. Wainwright & Maxim Group have both given Co-Diagnostics (Nasdaq: CODX) Buy rating with a $2.00 Price Target, almost double its price at Fridays close, suggesting the stock has a potential upside of +80%.
ethlend aave LEND:BTCprevious chart failed bat pattern, I'm still bullish on this guy!!
have a look at the Bullish DIV. it's displaying.
1 hr 2 hr 4 hr and daily all trending with bullish bias
+
descending wedge has formed, a few coins are displaying this, I'd say it's time to swing OUT of BTC and INTO ALTS for a short term!!
no target price really as yet, play 'er as she comes!
happy trading
thetradingtradie
DYOR
CRUUF "BULLISH" GOLDEN CROSSCRUUF is now displaying one of my favorite bullish signals - GOLDEN CROSS
Also, very bullish is its current buy opinion by one of Wall Street’s leading Technical indicators barchart.com, which just issued CRUUF an 80% "Buy" short term ! > Hence Time Sensitive?
DSS is our NYSE listed technical breakout pick. #79pctUpside
=====================
Our New Pick is: DSS
Current Price: $1.20
Float: 12.61M
Target Price: $2.15
Investor Presentation
========================
Members,
Act fast, and start your research on our latest trade idea DSS (Document Security Systems Inc.).
We've be scanning the market for the next big bullish breakout opportunity, and DSS really grabbed our attention today.
Based on our research, the chart on DSS is showing us a potential upside of nearly +80%.
This leader in anti-counterfeit, authentication, and diversion protection technologies, is due to get plenty attention from the Street tomorrow.
Here's why....
The Company's packaging and brand protection executives will be presenting the DSS platform of anti-counterfeiting technologies and packaging design to members of the global cannabis industry at MJBizCon being held at the Convention Center in Las Vegas, Nevada November 14-16.
“Cannabis products are quickly going mainstream which means they are fighting the same threats from fraud as other products. But with less mature supply chains and limited controls to protect against counterfeiting the threat is even greater for cannabis providers. DSS can assist these companies with supply chain security, anti-counterfeiting tools, and even printing and packaging solutions,” stated Mike Tobin, DSS VP Sales & Marketing.
The Company’s printing and packaging division, Premier Packaging, offers custom structural designs for folding cartons that are tailored for the cannabis market and their product offerings. Additional competencies include materials management, logistics, converting and inventory management programs; and when coupled with its product authentication technologies, gives DSS a strong value proposition to vertically integrated cannabis brands.
“The cannabis market is also heavily regulated with many states requiring tracking from seed to finished product along with proof that taxes and duties have been paid,” added Tobin. “We can provide companies with a comprehensive, very secure solution starting with a digital signature on the packaging all the way through to consumer engagement, including a blockchain-based option.”
DSS's customized product authentication solutions are powerful enough to protect against the most sophisticated forms of fraudulent activity, safeguarding brand integrity and value. Based on the Company’s patented AuthentiGuard™ technology, any authorized smart phone enables all supply chain personnel and consumers to easily authenticate products, and with the integrated GPS feature, it also has the ability to report diverted goods.
Additional features of AuthentiGuard™ include:
True 2-factor authentication
Secure tie-in to serialization and codes
Traceability from seed to finished product
Counterfeit resistant, patented technology which is secure against copying, scanning and high-resolution photography
Strong data collection capabilities with unified records management on individual plants & products
Iimmediate Bullish Catalysts for DSS:
The Company's packaging and brand protection executives will be presenting the DSS platform of anti-counterfeiting technologies and packaging design to members of the global cannabis industry at MJBizCon being held at the Convention Center tomorrow
Chart is looking extremely bullish at the moment.
Float is just 12.61M
Zero Insider Selling Within the Past 12-Months
On March 19, 2018, DSS announced its partnership with the Hong Kong Logistics and Supply Chain MultiTech R&D Centre (LSCM) to conduct research focused on developing the next generation of DSS’ Brand Protection products utilizing blockchain technology to secure product transactions across multiple channels, including retail and online distribution.
About Document Security Systems Inc.
For over 15 years, Document Security Systems, Inc. (“DSS”) has protected corporations, financial institutions, and governments from sophisticated and costly fraud. DSS' innovative anti-counterfeit, authentication, and brand protection solutions are deployed to prevent attacks which threaten products, digital presence, financial instruments, and identification. AuthentiGuard®, the company's flagship product, provides authentication capability through a smartphone application so businesses can empower a wide range of employees, supply chain personnel, and consumers to track their brands and verify authenticity. For more information on DSS, visit www.dsssecure.com.
Investor Highlights
Focused on high-growth commercialization and high-margin licensing opportunities
Valuable near-term growth opportunities with AuthentiGuard™ & other technology products
Entrance into Asia Pacific market represents significant opportunities within world’s largest counterfeit packaging market
DSS is advancing the Authentication Model from reactive to predictive, involving the use of data to validate product authenticity
Mobile authentication tool, allows all parties in the supply chain the ability to authenticate
Technology platform fills consumer demand for product authentication capability
Adding consumer generates very valuable data that will become cornerstone of businessstrategy and intelligence
Integration of data from supply chain will enable product origin and tracking, critical in food,beverage, health and beauty markets
Technical Analysis
RSI is Showing Bullish Divergence
15-Day Moving Average breaking above its 50-Day Moving Average, forming a "Golden Cross" (Major Bullish Indicator).
We are setting our price target for DSS at $2.15, which is an upside of nearly +80% from our $1.20 alert price.
We are feeling confident that DSS is going to go on multi-day bull run.
The chart is looking extremely attractive, and we believe that DSS will hit our target price of $2.15
We are excited to hear what news will come out of the upcoming MJBiz conference.
We could be looking at the NYSE's biggest winner tomorrow!
As such, we are urging all members to act fast, start their research, and make sure to have DSS up on your screen's and ready to trade.
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The PennyStock101 Team
Don't Miss Our Next Huge Winner...
Text 'PS101' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have not been compensated to conduct investor relations advertising and marketing for DSS. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Top 5 Coins With Best Performance During ConsolidationIt was a great rally across many cryptocurrencies during the past months. There was a huge growth by some coins, gaining x10, x20, x30 or more, where most cryptocurrency traders were profiting disregarding the coin of their choice.
However, there are always times of consolidation or a correction. And this time is now. The cryptomarket is not stagnating, which means that the coin either consolidating or correcting downwards.
But it does not happen to all coins because some will be always better than others and in the idea you can see the top 5 coins that had produced the biggest gains during January consolidation period.
Aquabounty Technologies INC, The Current Giant Gainer Aquabounty Technologies has been the biggest gainer currently and this gain came during a really bad performance. It was leveled at a strong channel of around 3.10 to around 3.30. It went on a very big bullish run and it broke 8.55 today on a very big scale. A downfall of 4.50 to around 5.10 can be expected. The stock will surely find support at 3.05 to 4.05 channel and keep that form until the end of February where it will have small upswings and downswings but it will definitely not lose its form of the channel.